163 related articles for article (PubMed ID: 8347483)
1. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.
Bracke ME; Vyncke BM; Bruyneel EA; Vermeulen SJ; De Bruyne GK; Van Larebeke NA; Vleminckx K; Van Roy FM; Mareel MM
Br J Cancer; 1993 Aug; 68(2):282-9. PubMed ID: 8347483
[TBL] [Abstract][Full Text] [Related]
2. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells.
De Leon DD; Wilson DM; Powers M; Rosenfeld RG
Growth Factors; 1992; 6(4):327-36. PubMed ID: 1340210
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
Guvakova MA; Surmacz E
Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype.
Bracke ME; Charlier C; Bruyneel EA; Labit C; Mareel MM; Castronovo V
Cancer Res; 1994 Sep; 54(17):4607-9. PubMed ID: 8062251
[TBL] [Abstract][Full Text] [Related]
6. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid.
Vermeulen SJ; Bruyneel EA; van Roy FM; Mareel MM; Bracke ME
Br J Cancer; 1995 Dec; 72(6):1447-53. PubMed ID: 8519658
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
8. Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16.
Boterberg T; Vennekens KM; Thienpont M; Mareel MM; Bracke ME
Cell Adhes Commun; 2000 Jan; 7(4):299-310. PubMed ID: 10714391
[TBL] [Abstract][Full Text] [Related]
9. Bowes melanoma cells secrete heregulin, which can promote aggregation and counteract invasion of human mammary cancer cells.
Stove C; Boterberg T; Van Marck V; Mareel M; Bracke M
Int J Cancer; 2005 Apr; 114(4):572-8. PubMed ID: 15609326
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
[TBL] [Abstract][Full Text] [Related]
11. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
13. Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells.
André F; Janssens B; Bruyneel E; van Roy F; Gespach C; Mareel M; Bracke M
Oncogene; 2004 Feb; 23(6):1177-86. PubMed ID: 14961074
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop.
Lahm H; Amstad P; Wyniger J; Yilmaz A; Fischer JR; Schreyer M; Givel JC
Int J Cancer; 1994 Aug; 58(3):452-9. PubMed ID: 8050827
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
16. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
[TBL] [Abstract][Full Text] [Related]
17. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
18. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.
Katzenellenbogen BS; Norman MJ
Endocrinology; 1990 Feb; 126(2):891-8. PubMed ID: 2404751
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
Parisot JP; Hu XF; DeLuise M; Zalcberg JR
Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
[TBL] [Abstract][Full Text] [Related]
20. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
